NCT00591032

Brief Summary

AQUA FONTIS is a unicentric, multidisciplinary, prospective cross-section and longitudinal study that aims at the development of a more clear-cut diagnostic definition and classification of non-thyroidal illness syndrome (NTIS).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
590

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2007

Longer than P75 for all trials

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 26, 2007

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 11, 2008

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2017

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

November 19, 2020

Status Verified

November 1, 2020

Enrollment Period

10.6 years

First QC Date

December 26, 2007

Last Update Submit

November 17, 2020

Conditions

Keywords

Critical illnessEuthyroid sick syndromesIntensive careNon-thyroidal illness syndromeLow-T3 syndrome

Outcome Measures

Primary Outcomes (1)

  • Assessment of the significance of an innovative physiological index approach (SPINA) in differential diagnosis between NTIS and latent thyrotoxicosis.

    Diagnostic accuracy (sensitivity, specificity and AUCs of ROC analysis) of the thyroid's calculated secretory capacity (GT) for differentiation between NTIS and subclinical hyperthyroidism.

    Three weeks after admission to ICU (evaluation point 1.5) and additionally on day of discharge from the hospital (evaluation point 1.999)

Secondary Outcomes (1)

  • Correlation of variables that quantify distinct components of NTIS with independent predictors of evolution, survival or pathophysiological condition and influencing or disturbing factors like medication.

    24 hours (evaluation point 1.1), 72 hours (evaluation point 1.2) and further on weekly (evaluation points 1.3 to 1.5) after admission to the intensive care unit up to the day of discharge from hospital (evaluation point 1.999)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critically ill patients treated at three intensive care units of the Bergmannsheil university hospitals and that comply with the eligibility criteria.

You may qualify if:

  • Severe illness requiring intensive care
  • Stay of at least 24 hours at the ICU

You may not qualify if:

  • Substituted hypothyroidism or substitution in case of thyroid carcinoma
  • Hyperthyroidism that is treated with thyrostatic agents and exhibits a THS level not below the reference region
  • Manifest AIDS disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Department for medical informatics, biometry and epidemiology, Ruhr-University of Bochum

Bochum, North Rhine-Westphalia, D-44780, Germany

Location

Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum

Bochum, North Rhine-Westphalia, D-44789, Germany

Location

Medical Hospital II, Bergmannsheil University Hospitals, Ruhr University of Bochum

Bochum, North Rhine-Westphalia, D-44789, Germany

Location

Medizinische Klinik I, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum

Bochum, North Rhine-Westphalia, D-44789, Germany

Location

Diabetes-Zentrum, Mathias-Spital

Rheine, North Rhine-Westphalia, D-48431, Germany

Location

Abteilung für Laboratoriums- und Transfusionsmedizin, Westpfalz-Klinikum Kaiserslautern

Kaiserslautern, Rhineland-Palatinate, D-67655, Germany

Location

Related Publications (7)

  • Dietrich JW, Stachon A, Antic B, Klein HH, Hering S. The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome. BMC Endocr Disord. 2008 Oct 13;8:13. doi: 10.1186/1472-6823-8-13.

    PMID: 18851740BACKGROUND
  • Dietrich JW, Landgrafe G, Fotiadou EH. TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis. J Thyroid Res. 2012;2012:351864. doi: 10.1155/2012/351864. Epub 2012 Dec 30.

    PMID: 23365787BACKGROUND
  • Dietrich JW, Muller P, Schiedat F, Schlomicher M, Strauch J, Chatzitomaris A, Klein HH, Mugge A, Kohrle J, Rijntjes E, Lehmphul I. Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling. Eur Thyroid J. 2015 Jun;4(2):129-37. doi: 10.1159/000381543. Epub 2015 May 23.

    PMID: 26279999BACKGROUND
  • Dietrich JW, Landgrafe-Mende G, Wiora E, Chatzitomaris A, Klein HH, Midgley JE, Hoermann R. Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research. Front Endocrinol (Lausanne). 2016 Jun 9;7:57. doi: 10.3389/fendo.2016.00057. eCollection 2016.

    PMID: 27375554BACKGROUND
  • Chatzitomaris A, Hoermann R, Midgley JE, Hering S, Urban A, Dietrich B, Abood A, Klein HH, Dietrich JW. Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming. Front Endocrinol (Lausanne). 2017 Jul 20;8:163. doi: 10.3389/fendo.2017.00163. eCollection 2017.

    PMID: 28775711BACKGROUND
  • Dietrich JW, Midgley JEM, Hoermann R. Editorial: "Homeostasis and Allostasis of Thyroid Function". Front Endocrinol (Lausanne). 2018 Jun 5;9:287. doi: 10.3389/fendo.2018.00287. eCollection 2018. No abstract available.

    PMID: 29922229BACKGROUND
  • Aweimer A, El-Battrawy I, Akin I, Borggrefe M, Mugge A, Patsalis PC, Urban A, Kummer M, Vasileva S, Stachon A, Hering S, Dietrich JW. Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study. J Intern Med. 2021 May;289(5):675-687. doi: 10.1111/joim.13189. Epub 2020 Nov 12.

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

Kryobase with serum and urine samples

MeSH Terms

Conditions

Euthyroid Sick SyndromesCritical Illness

Condition Hierarchy (Ancestors)

Thyroid DiseasesEndocrine System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Johannes W Dietrich, M.D.

    Medizinische Klinik I, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum

    PRINCIPAL INVESTIGATOR
  • Steffen Hering, M.D.

    Diabetes-Zentrum, Mathias-Spital Rheine

    STUDY DIRECTOR
  • H H Klein, M.D.

    Medizinische Klinik I, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior consultant endocrinologist

Study Record Dates

First Submitted

December 26, 2007

First Posted

January 11, 2008

Study Start

May 1, 2007

Primary Completion

November 30, 2017

Study Completion

December 31, 2020

Last Updated

November 19, 2020

Record last verified: 2020-11

Locations